Search filters

List of works by Lars Henrik Jensen

A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas

scientific article published on 29 July 2010

A parallel-group randomized clinical trial of individually tailored, multidisciplinary, palliative rehabilitation for patients with newly diagnosed advanced cancer: the Pal-Rehab study protocol

scientific article

Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III

scientific article published on 31 July 2015

Biliary-tract cancer: improving therapy by adding molecularly targeted agents

scientific article published on December 20, 2011

Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer.

scientific article

Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma.

scientific article published on April 2011

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer.

scientific article published on 16 May 2019

Cross-sectoral video consultations in cancer care: perspectives of cancer patients, oncologists and general practitioners

scientific article published on 21 April 2020

Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer.

scientific article published on 9 May 2015

Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib

scientific article published on 22 October 2018

EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

scientific article published on 22 October 2009

Fast identification of febrile neutropenia improves the outcome

scientific article published on August 2015

Gemcitabine, capecitabine and oxaliplatin in advanced biliary tract carcinoma

article

Gene expression of the mismatch repair gene MSH2 in primary colorectal cancer

scientific article published on July 6, 2011

High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study

scientific article published on 5 July 2015

How participatory action research changed our view of the challenges of shared decision-making training

scientific article published on 9 November 2017

Improving continuity by bringing the cancer patient, general practitioner and oncologist together in a shared video-based consultation - protocol for a randomised controlled trial

scientific article published on 25 June 2019

Investigating whether shared video-based consultations with patients, oncologists, and GPs can benefit patient-centred cancer care: a qualitative study

scientific article published on 01 April 2020

Local staging of sigmoid colon cancer using MRI.

scientific article published on 25 July 2017

Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment.

scientific article published on 21 April 2010

Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

scientific article published on 12 March 2018

NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer

scientific article published on 25 October 2019

Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial

scientific article published on 29 April 2015

Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer

scientific article published on February 23, 2012

Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers

scientific article published on 14 December 2019

Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment

scientific article published on 24 October 2018

Predictive value of MSH2 gene expression in colorectal cancer treated with capecitabine

scientific article published on 01 March 2007

Prognostic factors for progression-free and overall survival in advanced biliary tract cancer.

scientific article published on 19 October 2015

Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts

scientific article published on 14 November 2018

Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients

scientific article published on 12 February 2014

Pseudoprogression during treatment with pembrolizumab followed by rechallenge with chemotherapy in metastatic colorectal cancer: A case report

scientific article published on 18 June 2019

Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study

scientific article published on 29 November 2019

Randomized cross-over study of patient preference for oral or intravenous vinorelbine in combination with carboplatin in the treatment of advanced NSCLC.

scientific article published on 26 March 2008

Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study

scientific article published on 12 September 2013

Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers

scientific article published on 15 September 2020

Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency

scientific article published on 13 September 2007

Study protocol: a randomized controlled trial comparing the efficacy of therapist guided internet-delivered cognitive therapy (TG-iConquerFear) with augmented treatment as usual in reducing fear of cancer recurrence in Danish colorectal cancer survi

scientific article published on 16 March 2020

Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials

scientific article

Systemic treatment of biliary tract cancer

scientific article

The prognostic importance of thymidylate gene polymorphism in colon cancer stage II.

scientific article published on 16 July 2008

The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer

scientific article

The relationship between serum vascular endothelial growth factor A and microsatellite instability in colorectal cancer

scientific article published on 28 June 2010

Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial

scientific article published on 20 July 2020

Tumor-stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy

scientific article published on 5 October 2017

[Medical treatment of patients with colorectal cancer in Denmark]

scientific article published on 01 November 2018